dataset,birth.rate,mu.1,mu.2,mu.AA,mu.SA,beta,decline.beta,beta.age.1,beta.age.2,beta.stage.1,beta.stage.2,rel.inf.age.1,rel.inf.age.2,sigma,xi,rel.p.age.1,p.2,s,s2,phi.2,r1,rdiff,w,k,omega,increase.omega
low,0.017,0.017,0,0,0.05,1,0,1,1,1,1,1,1,1,0,0.2,0.025,0.5,0,0.00001,0.1,0,0.1,0.6,0.1,0
hi,0.017,0.017,0,0,0.75,100,0,1,1,1,1,1,1,1,1,1.2,0.05,0.5,0.2,0.006,5,0,2,0.97,1.5,0
diff,0,0,0,0,0.35,99,0,0,0,0,0,0,0,0,1,1,0.025,0,0.2,0.00599,4.9,0,1.9,0.37,1.4,0
description,,"background mortality, < 15s","background mortality, > 15s",mortality among asymptomatic,mortality among symptomatic,,annual decline in beta,relative infectiousness of < 15s,relative infectiousness of > 15s,relative infectiousness of subclinical TB,relative infectiousness of symptomatic TB,relative susceptibility of < 15s,relative susceptibility of > 15s,mixing between low and high risk groups - no longer relevant,"protection from reinfection (RR). 0 = 100% protection, 1= no protection",relative progression rate among < 15s,fast progression rate among adults,stabilization rate,clearance rate,slow progression/reactivation rate among adults,symptom progression rate,relative rate of symptom regression (vs. progression),spontaneous resolution rate ,treatment success ratio,treatment rate,annual increase in omega
